W. Lee Kraus, Ph.D. is Professor and Director of the Cecil H. and Ida Green Center for Reproductive Biology Sciences, Professor of Obstetrics & Gynecology and Pharmacology, Vice Chair for Basic Sciences and Chief, Division of Basic Research in the Department of Obstetrics & Gynecology, and Assistant Director for Basic Research in the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center. He is a trained biochemist, molecular biologist, and physiologist who has interests in hormone action, nuclear signaling pathways, chromatin structure, transcription, and the regulation of gene expression in biological systems including reproduction, inflammation, metabolism, stem cells, and cancer. His laboratory applies a broad array of approaches, from biophysics, biochemistry, and molecular biology, to cell biology, genomics, and mouse genetics, to study the detailed molecular mechanisms that control normal and disease phenotypes.
Dr. Kraus received a B.S. in Physiology from Cornell University in 1989 and completed his graduate research on the regulation of steroid hormone receptor activity in the laboratory of Dr. Benita S. Katzenellenbogen at the University of Illinois, Urbana-Champaign in 1994. He completed his postdoctoral research on the mechanisms of transcriptional regulation with chromatin in the laboratory of Dr. Jim Kadonaga at the University of California, San Diego in 1999. During his postdoctoral work, Dr. Kraus was supported by fellowships from the National Institutes of Health and the American Cancer Society, California Division.
Prior to joining the faculty at UT Southwestern, Dr. Kraus was a professor in the Department of Molecular Biology and Genetics at Cornell University in Ithaca, New York in 1999. He also held a joint appointment in the Department of Pharmacology at the Weill Medical College of Cornell University in New York City.
In July 2010, Dr. Kraus moved to UT Southwestern Medical Center in Dallas where he holds the Cecil H. and Ida Green Distinguished Chair in Reproductive Biology Sciences. He has received numerous awards, including a Burroughs Wellcome Fund Career Award in the Biomedical Sciences, the Cornell University College of Agriculture and Life Sciences Young Faculty Teaching Excellence Award, and the Richard E. Weitzman Memorial Award from the Endocrine Society.
Dr. Kraus has been supported by a Career Award in the Biomedical Sciences/Reproductive Biology from the Burroughs Wellcome Fund, as well as grants from the National Institutes of Health, Cancer Prevention Research Institute of Texas, the American Cancer Society, the Endocrine Society, and the Komen Breast Cancer Foundation.
Dr. Kraus is a founder of Ribon Therapeutics. Ribon Therapeutics is pioneering the discovery and development of PARP monoenzyme inhibitors to block cancer cells' fundamental ability to survive under stress.